BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 34735022)

  • 1. Management recommendations for pancreatic manifestations of von Hippel-Lindau disease.
    Laks S; van Leeuwaarde R; Patel D; Keutgen XM; Hammel P; Nilubol N; Links TP; Halfdanarson TR; Daniels AB; Tirosh A;
    Cancer; 2022 Feb; 128(3):435-446. PubMed ID: 34735022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two Childhood Pheochromocytoma Cases due to von Hippel-Lindau Disease, One Associated with Pancreatic Neuroendocrine Tumor: A Very Rare Manifestation.
    Dağdeviren Çakır A; Turan H; Aykut A; Durmaz A; Ercan O; Evliyaoğlu O
    J Clin Res Pediatr Endocrinol; 2018 Jun; 10(2):179-182. PubMed ID: 29022557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine manifestations of von Hippel-Lindau disease.
    Cassol C; Mete O
    Arch Pathol Lab Med; 2015 Feb; 139(2):263-8. PubMed ID: 25611110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Von Hippel-Lindau disease: molecular pathological basis, clinical criteria, genetic testing, clinical features of tumors and treatment.
    Shuin T; Yamasaki I; Tamura K; Okuda H; Furihata M; Ashida S
    Jpn J Clin Oncol; 2006 Jun; 36(6):337-43. PubMed ID: 16818478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastases to hemangioblastomas in von Hippel-Lindau disease.
    Jarrell ST; Vortmeyer AO; Linehan WM; Oldfield EH; Lonser RR
    J Neurosurg; 2006 Aug; 105(2):256-63. PubMed ID: 17219831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Von Hippel-Lindau disease: strategies in early detection (renal-, adrenal-, pancreatic masses).
    Hes FJ; Feldberg MA
    Eur Radiol; 1999; 9(4):598-610. PubMed ID: 10354869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consensus Guidelines for Ocular Surveillance of von Hippel-Lindau Disease.
    Daniels AB; Chang EY; Chew EY; Gombos DS; Gorin MB; Shields CL; Wiley HE
    Ophthalmology; 2024 May; 131(5):622-633. PubMed ID: 38092079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive characterization and building of National Registry of von Hippel-Lindau disease in Brazil.
    Dallagnol TN; Da Cás E; Junior OR; Casali-da-Rocha JC
    Mol Genet Genomic Med; 2023 Apr; 11(4):e2136. PubMed ID: 36625343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurologic manifestations of von Hippel-Lindau disease.
    Butman JA; Linehan WM; Lonser RR
    JAMA; 2008 Sep; 300(11):1334-42. PubMed ID: 18799446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel and recurrent germline mutations in the VHL gene in 5 Arab patients with Von Hippel-Lindau disease.
    Faiyaz-Ul-Haque M; Jamil M; Aslam M; Abalkhail H; Al-Dayel F; Basit S; Nawaz Z; Zaidi SHE
    Cancer Genet; 2020 May; 243():1-6. PubMed ID: 32179488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetics and angiogenesis: the example of von Hippel-Lindau disease].
    Richard S; Ladroue C; Gad S; Giraud S; Gardie B;
    Bull Cancer; 2007 Jul; 94 Spec No():S170-9. PubMed ID: 17846002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. von Hippel-Lindau disease: Updated guideline for diagnosis and surveillance.
    Louise M Binderup M; Smerdel M; Borgwadt L; Beck Nielsen SS; Madsen MG; Møller HU; Kiilgaard JF; Friis-Hansen L; Harbud V; Cortnum S; Owen H; Gimsing S; Friis Juhl HA; Munthe S; Geilswijk M; Rasmussen ÅK; Møldrup U; Graumann O; Donskov F; Grønbæk H; Stausbøl-Grøn B; Schaffalitzky de Muckadell O; Knigge U; Dam G; Wadt KA; Bøgeskov L; Bagi P; Lund L; Stochholm K; Ousager LB; Sunde L
    Eur J Med Genet; 2022 Aug; 65(8):104538. PubMed ID: 35709961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. von Hippel-Lindau disease: a clinical and scientific review.
    Maher ER; Neumann HP; Richard S
    Eur J Hum Genet; 2011 Jun; 19(6):617-23. PubMed ID: 21386872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric pheochromocytoma in association with Von Hippel-Lindau disease: Focus on screening strategies.
    Vérot PL; Rabattu PY; Chabre O; Gayot A; Sartelet H; Faguet R; Robert Y; Piolat C
    Arch Pediatr; 2020 Nov; 27(8):497-501. PubMed ID: 33067065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. von Hippel-Lindau syndrome.
    Chou A; Toon C; Pickett J; Gill AJ
    Front Horm Res; 2013; 41():30-49. PubMed ID: 23652669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic study of a large Chinese kindred with von Hippel-Lindau disease.
    Huang YR; Zhang J; Wang JD; Fan XD
    Chin Med J (Engl); 2004 Apr; 117(4):552-7. PubMed ID: 15109448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two pediatric patients with Von Hippel-Lindau disease type 2b: from patient to screening, from screening to patient.
    Gonc N; Engiz O; Neumann HP; Demirbilek H; Ozon A; Alikasifoglu A; Kandemir N
    J Pediatr Endocrinol Metab; 2011; 24(1-2):109-12. PubMed ID: 21528828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico VHL Gene Mutation Analysis and Prognosis of Pancreatic Neuroendocrine Tumors in von Hippel-Lindau Disease.
    Tirosh A; El Lakis M; Green P; Nockel P; Patel D; Nilubol N; Gara SK; Keutgen XM; Linehan WM; Kebebew E
    J Clin Endocrinol Metab; 2018 Apr; 103(4):1631-1638. PubMed ID: 29294023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidelines for surveillance of patients with von Hippel-Lindau disease: Consensus statement of the International VHL Surveillance Guidelines Consortium and VHL Alliance.
    Daniels AB; Tirosh A; Huntoon K; Mehta GU; Spiess PE; Friedman DL; Waguespack SG; Kilkelly JE; Rednam S; Pruthi S; Jonasch EA; Baum L; Chahoud J;
    Cancer; 2023 Oct; 129(19):2927-2940. PubMed ID: 37337409
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.